Dr. Raphael Kiwon Sung, MD

Dr. Sung practices at National Jewish Health in Denver, Colorado, part of National Jewish Health.

Dr. Sung's NPI, 1962567206, was assigned on December 27, 2006. Dr. Sung graduated from Perelman School of Med at the University of Pennsylvania in 2005. Dr. Sung holds Colorado license 51454.

Dr. Sung's primary practice is National Jewish Health, at 1400 Jackson St, Denver, CO 80206 in Denver County. The practice phone is (303) 388-4461.

Dr. Sung's primary practice is National Jewish Health in Denver, Colorado, part of National Jewish Health. Dr. Sung is also affiliated with Saint Joseph Hospital. The medical group on file is Intermountain Health. Dmand AI also links Dr. Sung to 3 more hospitals and 2 medical groups, each named with a free account. Dr. Sung's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sung practices, 5 sites in all. Vendor and product names are available with a free account.

Clinical cardiac electrophysiology is Dr. Sung's primary specialty in the NPI Registry, under taxonomy code 207RC0001X. Dmand AI has Dr. Sung's licenses on file in 2 states: Colorado and California.

CMS data shows 1,142 Medicare services from Dr. Sung across 20 procedure codes in 2024, for 442 Medicare patients. Medicare paid $114,941 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 442 Medicare patients who saw Dr. Sung in 2024. The largest group is 75 to 84, with 188 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sung's median patient age at 76, with 45% women.

In 2024, Dr. Sung wrote 425 Medicare Part D claims for 145 patients. 54% of them were for generic drugs. CMS names the drug for 362 of them, across 9 drugs with 11 or more claims each, at $247,613 in total drug cost. In 2023, CMS named 316 claims across 7 drugs.

Dr. Sung accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sung as offering telehealth. CMS counts 26 procedures of pacemaker insertion or repair by Dr. Sung, more than 75% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Sung, published from 2010 to 2021. 2012 was the busiest year, with 2. The most frequent topics are Defibrillators, Implantable, Electrophysiologic Techniques, Cardiac and Arrhythmias, Cardiac. Dr. Sung has published most often in J Cardiovasc Electrophysiol. Dr. Sung's most frequent co-authors are Melvin M. Scheinman, MD, Paul Donald Varosy, MD and Ryan G. Aleong, MD.

CMS Open Payments shows 366 general payments to Dr. Sung from 29 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 52% of the total. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) paid the most, $46,306.

Dr. Sung graduated from Perelman School of Med at the University of Pennsylvania in 2005.